Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression

BACKGROUND: Atrial fibrillation (AF) patients frequently require anticoagulation with vitamin K antagonists (VKAs) to prevent thromboembolic events, but their use increases the risk of hemorrhage. We evaluated time spent in therapeutic range (TTR), proportion of international normalized ratio (INR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mearns, Elizabeth S, White, C Michael, Kohn, Christine G, Hawthorne, Jessica, Song, Ju-Sung, Meng, Joy, Schein, Jeff R, Raut, Monika K, Coleman, Craig I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094926/
https://www.ncbi.nlm.nih.gov/pubmed/25024644
http://dx.doi.org/10.1186/1477-9560-12-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094926/
https://www.ncbi.nlm.nih.gov/pubmed/25024644
http://dx.doi.org/10.1186/1477-9560-12-14

Ejemplares similares